caffeine has been researched along with pentoxifylline in 80 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (13.75) | 18.7374 |
1990's | 29 (36.25) | 18.2507 |
2000's | 21 (26.25) | 29.6817 |
2010's | 14 (17.50) | 24.3611 |
2020's | 5 (6.25) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Abraham, MH; Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Jacobson, KA; Kim, HS; Kim, SA; Linden, J; Marshall, MA; Melman, N; Müller, CE | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Andersen, OA; Demartino, JA; Rao, FV; van Aalten, DM; Vora, KA | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Gwizdek-Wiśniewska, A; Piosik, J; Ulanowska, K; Wegrzyn, G | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Gołuński, G; Iermak, I; Piosik, J; Rychłowski, M; Woziwodzka, A | 1 |
Mohamed, T; Osman, W; Rao, PP; Tin, G | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Aparicio, NJ; De Turner, E; Schwarzstein, L; Turner, D | 1 |
Blank, KJ; Klyczek, KK; Rosenthal, LA | 1 |
Carreras, A; Mendoza, C; Tesarik, J | 1 |
Albertson, TE; Derlet, RW; Tseng, JC | 1 |
Mitsumoto, Y; Mohri, T; Ohkubo, T | 1 |
Averette, HE; Perras, J; Ramos, R; Schiano, MA; Sevin, BU; Wolloch, EH | 1 |
Averette, HE; Boike, GM; Chou, TC; Donato, D; Hilsenbeck, SG; Penalver, M; Perras, J; Petru, E; Schiano, M; Sevin, BU | 1 |
Chan, JC; Crowley, JJ; Hatherill, JR; Hoffmann, H; Ishizaka, A; Raffin, TA; Zheng, H | 1 |
Ford, WC; Hull, MG; Rees, JM | 1 |
Bedia, E; Donovan, JF; Hammitt, DG; Rogers, PR; Syrop, CH; Williamson, RA | 1 |
Sasaki, T; Tomita, K; Tsuchiya, H | 1 |
le Petit, G | 1 |
Fredholm, BB; Lindström, K | 1 |
Aguilar, JS; Lowenstein, PR; Sabato, UC | 1 |
Chang, JD; Fingert, HJ; Pardee, AB | 1 |
Boivin, P; Galand, C; Lecomte, MC | 1 |
Boivin, P; Lecomte, MC | 1 |
Jakovljević, V | 1 |
Cardinali, DP; Izquierdo, JA | 1 |
Kamphuis, J; Smits, P; Thien, T | 1 |
Adams, EG; Bhuyan, BK; Folz, BA; Smith, KS | 1 |
Hirota, S; Iwazaki, A; Miyagishima, A; Nozawa, Y; Sadzuka, Y | 1 |
Charland, SL; Melko, GP; Stanek, EJ | 1 |
Hosaka, M; Iwasaki, A; Kanno, H; Kawakami, Y; Kinoshita, Y; Saito, K; Sato, K | 1 |
Scott, L; Smith, S | 1 |
Greer, BE; Griffin, TW; Koh, WJ; Kurtz, H; Stelzer, KJ | 1 |
Ford, WC; Hull, MG; Ling, L; McLaughlin, EA; Rees, JM | 1 |
Chapman, MG; Forman, RG; Gearon, CM; Guglielmino, A; Lanzafame, F | 1 |
Baker, GH; Johnston, RC; Mbizvo, MT | 1 |
Agarwal, A; Sharma, RK; Thomas, AJ; Tolentino, MV | 1 |
Agarwal, A; Sharma, RK; Tolentino, MV | 1 |
Langermans, JA; Seijmonsbergen, EM; van der Meide, PH; van Furth, AM; van Furth, R | 1 |
Barnes, RC; Carper, HT; Luong, LS; Mandell, GL; Sullivan, GW | 1 |
Barancík, M; Breier, A; Stefanková, Z | 1 |
Evans, G; Maxwell, WM; Molinia, FC; Robinson, SJ; Roca, J; Sánchez-Partida, LG | 1 |
Akaike, N; Kawa, K; Uneyama, H | 1 |
Aparicio, M; Cambar, J; Potier, M | 1 |
Addae, JI; Evans, SM; Pinto Pereira, LM | 1 |
Campos, AR; Paula, WG; Rao, VS; Santos, FA; Silva, RM | 1 |
Daly, JW; Shi, D | 1 |
Binder, A; Bohm, L; Theron, T | 1 |
Korn, N; Parkhurst, AM; Thurston, RJ | 1 |
Boobis, AR; Edwards, RJ; Murray, BP; Murray, S; Odupitan, AO | 1 |
Eshleman, JS; Sarkaria, JN | 1 |
Czyz, A; Gwizdek-Wiśniewska, A; Kapuściński, J; Piosik, J; Ulanowska, K; Wegrzyn, G | 1 |
Czyz, A; Gwizdek-Wiśniewska, A; Ochociński, J; Piosik, J; Ulanowska, K; Wegrzyn, G | 1 |
Ulanowska, K; Wegrzyn, G | 1 |
Anderson, CM; Thwaites, DT | 1 |
Bulaeva, SV; Chuchkanov, FA; Maimistova, AA; Muravyov, AV; Yakusevich, VV; Zaitsev, LG | 1 |
Horvath, B; Kesmarky, G; Toth, K; Vekasi, J | 1 |
Budach, V; Grassl, B; Schroeder, G; Schulze, J; Sinn, B; Tallen, G; Tinhofer, I | 1 |
Fontbonne, A; Gérard, O; Milani, C; Romagnoli, S; Sellem, E; Stelletta, C | 1 |
Gwizdek-Wiśniewska, A; Piosik, J; Woziwodzka, A | 1 |
Ebrahim-Habibi, A; Kashani-Amin, E; Larijani, B; Yaghmaei, P | 1 |
Barakat, IA; Danfour, MA; Dkhil, MA; Galewan, FA | 1 |
Byrne, PG; Keogh, LM; Silla, AJ | 1 |
Batty, KT; Hibbert, J; Manning, L; Page-Sharp, M; Patole, SK; Salman, S; Strunk, T | 1 |
Camillo, F; Ciaramelli, A; Panzani, D; Przybył, A; Rota, A; Sabatini, C | 1 |
Falomo, ME; Gonzalez-Castro, R; Rossi, M | 1 |
Al-Mahmood Siddiquee, A; Hashemian, F; Monji, F | 1 |
Bachmann, CM; Grimm, HS; Grimm, MOW; Hartmann, T; Janitschke, D; Lauer, AA; Seyfried, M | 1 |
Borowik, A; Felberg, A; Gołuński, G; Krychowiak-Maśnicka, M; Piosik, J; Woziwodzka, A; Wyrzykowski, D | 1 |
Bachmann, CM; Griebsch, LV; Grimm, HS; Grimm, MOW; Hartmann, T; Janitschke, D; Lauer, AA; Pilz, SM; Theiss, EL; Winkler, J | 1 |
5 review(s) available for caffeine and pentoxifylline
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Xanthine interference with dipyridamole-thallium-201 myocardial imaging.
Topics: Adenosine; Animals; Caffeine; Coronary Disease; Dipyridamole; Dogs; False Negative Reactions; Heart; Humans; Male; Pentoxifylline; Radionuclide Imaging; Thallium Radioisotopes; Xanthine; Xanthines | 1995 |
Pharmacological stimulation of sperm motility.
Topics: Caffeine; Deoxyadenosines; Humans; Infertility, Male; Male; Pentoxifylline; Relaxin; Sperm Motility; Theophylline | 1994 |
ATM as a target for novel radiosensitizers.
Topics: Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Caffeine; Cell Cycle; Cell Cycle Proteins; Chromosome Aberrations; DNA Damage; DNA Repair; DNA-Binding Proteins; Humans; Neoplasms; Pentoxifylline; Phosphodiesterase Inhibitors; Protein Serine-Threonine Kinases; Radiation Tolerance; Radiation-Sensitizing Agents; Signal Transduction; Tumor Suppressor Proteins | 2001 |
Can pentoxifylline and similar xanthine derivatives find a niche in COVID-19 therapeutic strategies? A ray of hope in the midst of the pandemic.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Caffeine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Infant, Newborn; Infant, Premature; Inflammation; Pandemics; Pentoxifylline; Pneumonia, Viral; Xanthines | 2020 |
75 other study(ies) available for caffeine and pentoxifylline
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogPoct: a tool for lipophilicity determination in drug discovery.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Solvents | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Structure-activity relationships at human and rat A2B adenosine receptors of xanthine derivatives substituted at the 1-, 3-, 7-, and 8-positions.
Topics: Animals; Binding, Competitive; Cell Line; Cloning, Molecular; Humans; Ligands; Purinergic P1 Receptor Antagonists; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2B; Receptors, Purinergic P1; Recombinant Proteins; Structure-Activity Relationship; Xanthines | 2002 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Methylxanthine drugs are chitinase inhibitors: investigation of inhibition and binding modes.
Topics: Chitinases; Enzyme Inhibitors; Models, Molecular; Molecular Structure; Protein Binding; Xanthines | 2005 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Impaired mutagenic activities of MPDP(+) (1-methyl-4-phenyl-2,3-dihydropyridinium) and MPP(+) (1-methyl-4-phenylpyridinium) due to their interactions with methylxanthines.
Topics: 1-Methyl-4-phenylpyridinium; Caffeine; Calorimetry; Drug Interactions; Models, Molecular; Molecular Structure; Mutagens; Pentoxifylline; Pyridinium Compounds; Spectrophotometry, Atomic; Vibrio | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Modulation of acridine mutagen ICR191 intercalation to DNA by methylxanthines--analysis with mathematical models.
Topics: Aminacrine; Animals; Caffeine; Cattle; DNA; Drug Antagonism; Epithelial Cells; Intercalating Agents; Kidney; Kinetics; Models, Chemical; Mutagens; Nitrogen Mustard Compounds; Pentoxifylline; Salmonella typhimurium; Theophylline; Thermodynamics | 2013 |
Selective inhibition of human acetylcholinesterase by xanthine derivatives: in vitro inhibition and molecular modeling investigations.
Topics: Acetylcholinesterase; Binding Sites; Butyrylcholinesterase; Caffeine; Catalytic Domain; Cholinesterase Inhibitors; Humans; Hydrogen Bonding; Molecular Docking Simulation; Pentoxifylline; Protein Binding; Thermodynamics; Xanthine; Xanthines | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effect of two phosphodiesterase inhibitors, cyclic adenosine 3':5'-monophosphate, and a beta-blocking agent on human sperm motility.
Topics: Adolescent; Adult; Bucladesine; Caffeine; Humans; Male; Pentoxifylline; Propranolol; Sperm Motility; Theobromine; Time Factors | 1978 |
Interferon-alpha/beta, pentoxifylline, and caffeine synergize with interferon-gamma to induce major histocompatibility complex class I expression on a constitutively class I-negative murine tumor cell line.
Topics: Animals; Antibodies, Monoclonal; Caffeine; Cytokines; Dibutyryl Cyclic GMP; Drug Synergism; Flow Cytometry; Fluorescent Antibody Technique; Genes, MHC Class I; HLA-D Antigens; Interferon Type I; Interferon-gamma; Mice; Mice, Inbred BALB C; Pentoxifylline; Recombinant Proteins; Tumor Cells, Cultured | 1992 |
Effects of phosphodiesterase inhibitors caffeine and pentoxifylline on spontaneous and stimulus-induced acrosome reactions in human sperm.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acrosome; Caffeine; Calcimycin; Female; Follicular Fluid; Humans; Male; Pentoxifylline | 1992 |
Potentiation of cocaine and d-amphetamine toxicity with caffeine.
Topics: 2-Chloroadenosine; Animals; Caffeine; Cocaine; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Synergism; Male; Pentoxifylline; Poisoning; Rats; Rats, Inbred Strains; Seizures | 1992 |
Characterization of the uptake of adenosine by cultured rat hippocampal cells and inhibition of the uptake by xanthine derivatives.
Topics: 2-Chloroadenosine; Adenosine; Affinity Labels; Animals; Biological Transport; Caffeine; Cells, Cultured; Cytarabine; Dipyridamole; Embryo, Mammalian; Hippocampus; Kinetics; Neuroglia; Neurons; Pentoxifylline; Rats; Sodium; Theophylline; Thioinosine; Tritium; Xanthines | 1991 |
In vitro enhancement of cis-platinum antitumor activity by caffeine and pentoxifylline in a human ovarian cell line.
Topics: Antineoplastic Combined Chemotherapy Protocols; Caffeine; Cell Cycle; Cell Survival; Cisplatin; DNA, Neoplasm; Drug Synergism; Female; Flow Cytometry; G2 Phase; Humans; Kinetics; Neoplasm Proteins; Nuclear Proteins; Ovarian Neoplasms; Pentoxifylline; Trypan Blue; Tumor Cells, Cultured | 1991 |
Chemical enhancement of cisplatin cytotoxicity in a human ovarian and cervical cancer cell line.
Topics: Adenosine Triphosphate; Benzamides; Caffeine; Cells, Cultured; Cisplatin; Dose-Response Relationship, Drug; Drug Resistance; Drug Synergism; Female; Humans; In Vitro Techniques; Ovarian Neoplasms; Pentoxifylline; Poly(ADP-ribose) Polymerases; Uterine Cervical Neoplasms | 1990 |
Attenuation of tumor necrosis factor-induced endothelial cell cytotoxicity and neutrophil chemiluminescence.
Topics: Aminophylline; Animals; Bucladesine; Caffeine; Cattle; Cell Survival; Cells, Cultured; Chromium Radioisotopes; Colforsin; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; Neutrophils; Pentoxifylline; Tumor Necrosis Factor-alpha | 1990 |
Effect of caffeine and of pentoxifylline on the motility and metabolism of human spermatozoa.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Caffeine; Humans; Male; Pentoxifylline; Sperm Motility; Spermatozoa; Stimulation, Chemical | 1990 |
Comparison of motility stimulants for cryopreserved human semen.
Topics: Adenosine; Animals; Caffeine; Calcium; Cricetinae; Cyclic AMP; Deoxyadenosines; Female; Humans; Kallikreins; Male; Pentoxifylline; Relaxin; Semen Preservation; Sperm Motility; Sperm-Ovum Interactions | 1989 |
[DNA repair and drug resistance: enhancement of the effects of anticancer agents by DNA repair inhibitors].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Caffeine; Cell Division; Child; Cisplatin; DNA Repair; Doxorubicin; Drug Resistance; Drug Synergism; Humans; Male; Middle Aged; Osteosarcoma; Pentoxifylline; Theophylline; Tumor Cells, Cultured | 1989 |
[The pH-dependent lipid solubility of drug groups].
Topics: Adrenergic beta-Antagonists; Anesthetics, Local; Caffeine; Clofibrate; Hydrogen-Ion Concentration; Lipids; Pentoxifylline; Pharmaceutical Preparations; Solubility | 1985 |
The xanthine derivative 1-(5'-oxohexyl)-3-methyl-7-propyl xanthine (HWA 285) enhances the actions of adenosine.
Topics: Adenosine; Animals; Biological Transport; Caffeine; Cyclic AMP; Drug Synergism; Erythrocyte Membrane; Hippocampus; Humans; Pentoxifylline; Rats; Receptors, Cell Surface; Receptors, Purinergic; Structure-Activity Relationship; Theobromine; Xanthines | 1986 |
Effects of the methylxanthine derivative pentoxifylline on benzodiazepine and muscarinic binding sites in rat cerebral cortex.
Topics: Animals; Binding, Competitive; Caffeine; Cerebral Cortex; Female; Flunitrazepam; Pentoxifylline; Quinuclidinyl Benzilate; Rats; Rats, Inbred Strains; Receptors, GABA-A; Receptors, Muscarinic; Theobromine | 1985 |
Cytotoxic, cell cycle, and chromosomal effects of methylxanthines in human tumor cells treated with alkylating agents.
Topics: Alkylating Agents; Caffeine; Cell Cycle; Cell Line; Cell Survival; Chromosome Aberrations; Chromosomes; Drug Synergism; Humans; Interphase; Mechlorethamine; Pentoxifylline; Theobromine; Thiotepa; Urinary Bladder Neoplasms | 1986 |
Inhibition of human erythrocyte casein kinase by methylxanthines. Study of inhibition mechanism.
Topics: Caffeine; Casein Kinases; Caseins; Erythrocytes; Humans; Kinetics; Pentoxifylline; Protein Kinase Inhibitors; Protein Kinases; Theobromine | 1980 |
Filterability and pharmacology. Effects of methylxanthine derivatives on red cell phosphorylation.
Topics: Adenosine Triphosphate; Caffeine; Casein Kinases; Erythrocyte Membrane; Erythrocytes; Humans; Micropore Filters; Pentoxifylline; Phosphorylation; Protein Kinases; Xanthines | 1981 |
[The effect of methylxanthine on myocardial excitability].
Topics: Animals; Caffeine; Female; Guinea Pigs; Heart Rate; Lidocaine; Male; Pentoxifylline; Xanthines | 1982 |
Effect of caffeine, aminophylline and pentoxifylline on memory processes in mice.
Topics: Aminophylline; Animals; Caffeine; Male; Memory; Mice; Pentoxifylline; Theobromine | 1981 |
Vascular effects of pentoxifylline in humans.
Topics: Adenosine; Adult; Caffeine; Dose-Response Relationship, Drug; Drug Interactions; Female; Forearm; Hemodynamics; Humans; Infusions, Intra-Arterial; Male; Muscle, Smooth, Vascular; Pentoxifylline; Receptors, Purinergic P1; Vasodilation | 1994 |
Synergistic and additive combinations of several antitumor drugs and other agents with the potent alkylating agent adozelesin.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aphidicolin; Azacitidine; Benzofurans; Caffeine; Cell Survival; CHO Cells; Cisplatin; Cricetinae; Cricetulus; Cyclohexanecarboxylic Acids; Cyclohexenes; Decitabine; Deoxyadenosines; DNA; Dose-Response Relationship, Drug; Drug Synergism; Duocarmycins; Indoles; Melanoma, Experimental; Melphalan; Mutagens; Organoplatinum Compounds; Pentoxifylline; Tumor Cells, Cultured | 1995 |
Effects of methylxanthine derivatives on adriamycin concentration and antitumor activity.
Topics: Animals; Caffeine; Carcinoma, Ehrlich Tumor; Doxorubicin; Drug Synergism; Male; Mice; Pentoxifylline; Theobromine; Theophylline | 1995 |
[Effect of caffeine and pentoxifylline on human sperm motility after one week storage at 3 degrees C].
Topics: Adult; Caffeine; Humans; Male; Pentoxifylline; Refrigeration; Semen Preservation; Sperm Motility; Time Factors | 1995 |
Human sperm motility-enhancing agents have detrimental effects on mouse oocytes and embryos.
Topics: Animals; Caffeine; Cyclic AMP; Deoxyadenosines; Embryo, Mammalian; Embryonic and Fetal Development; Female; Humans; Male; Mice; Parthenogenesis; Pentoxifylline; Sperm Motility | 1995 |
Caffeine consumption is associated with decreased severe late toxicity after radiation to the pelvis.
Topics: Caffeine; Endometrial Neoplasms; Female; Humans; Pelvis; Pentoxifylline; Radiation-Protective Agents; Radiotherapy; Retrospective Studies; Uterine Cervical Neoplasms | 1994 |
Pentoxifylline acts synergistically with A23187 to increase the penetration of zona-free hamster oocytes by cryopreserved human spermatozoa.
Topics: Acrosome; Animals; Caffeine; Calcimycin; Cricetinae; Cryopreservation; Drug Synergism; Female; Humans; In Vitro Techniques; Male; Ovum; Pentoxifylline; Semen Preservation; Sperm Motility; Sperm-Ovum Interactions; Spermatozoa; Zona Pellucida | 1994 |
The effect of the motility stimulants, caffeine, pentoxifylline, and 2-deoxyadenosine on hyperactivation of cryopreserved human sperm.
Topics: Caffeine; Computers; Cryopreservation; Deoxyadenosines; Humans; Male; Pentoxifylline; Semen Preservation; Sperm Motility; Spermatozoa | 1993 |
Optimal dose and duration of exposure to artificial stimulants in cryopreserved human spermatozoa.
Topics: Caffeine; Cryopreservation; Deoxyadenosines; Humans; Male; Pentoxifylline; Sperm Motility; Spermatozoa; Stimulation, Chemical; Time Factors | 1996 |
Sperm kinematics of cryopreserved normozoospermic specimens after artificial stimulation.
Topics: Caffeine; Cryopreservation; Deoxyadenosines; Humans; Male; Pentoxifylline; Sperm Motility | 1996 |
Effect of xanthine derivates and dexamethasone on Streptococcus pneumoniae-stimulated production of tumor necrosis factor alpha, interleukin-1 beta (IL-1 beta), and IL-10 by human leukocytes.
Topics: Caffeine; Cytokines; Dexamethasone; Glucocorticoids; Humans; Interleukin-1; Interleukin-10; Leukocytes; Pentoxifylline; Streptococcus pneumoniae; Theophylline; Tumor Necrosis Factor-alpha; Xanthines | 1995 |
Methylxanthines with adenosine alter TNF alpha-primed PMN activation.
Topics: Adenosine; Caffeine; Humans; Kinetics; Luminescent Measurements; Neutrophil Activation; Neutrophils; Pentoxifylline; Peroxidase; Superoxides; Tumor Necrosis Factor-alpha | 1995 |
Overcoming of P-glycoprotein mediated vincristine resistance of L1210/VCR mouse leukemic cells could be induced by pentoxifyline but not by theophylline and caffeine.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caffeine; Calcium; Calcium Channels; Drug Interactions; Drug Resistance, Neoplasm; Leukemia L1210; Mice; Pentoxifylline; Phosphodiesterase Inhibitors; Theophylline; Tumor Necrosis Factor-alpha; Vincristine | 1996 |
Motility, acrosome integrity and fertility of frozen ram spermatozoa treated with caffeine, pentoxifylline, cAMP, 2-deoxyadenosine and kallikrein.
Topics: Acrosome; Animals; Caffeine; Cryopreservation; Cyclic AMP; Deoxyadenosines; Female; Fertilization; Kallikreins; Male; Pentoxifylline; Pregnancy; Sheep; Sperm Motility; Spermatozoa | 1995 |
Inhibitory effect of methylxanthines on glycine-induced Cl current in dissociated rat hippocampal neurons.
Topics: Animals; Caffeine; Chloride Channels; Evoked Potentials; Glycine; Hippocampus; In Vitro Techniques; Pentoxifylline; Pyramidal Cells; Rats; Rats, Wistar; Theobromine; Theophylline; Xanthines | 1993 |
Protective effect of three xanthine derivatives (theophylline, caffeine and pentoxifylline) against the cyclosporin A-induced glomerular contraction in isolated glomeruli and cultured mesangial cells.
Topics: Animals; Caffeine; Cells, Cultured; Cyclosporine; Fluorescent Antibody Technique, Indirect; Glomerular Mesangium; Immunosuppressive Agents; In Vitro Techniques; Kidney Glomerulus; Male; Muscle Contraction; Pentoxifylline; Rats; Rats, Sprague-Dawley; Theophylline; Xanthines | 1997 |
Neuroprotection by caffeine and pentoxifylline during experimental cerebral ischaemia.
Topics: Animals; Brain Ischemia; Caffeine; Central Nervous System Stimulants; Cerebral Cortex; Disease Models, Animal; Evoked Potentials, Somatosensory; Male; Neuroprotective Agents; Pentoxifylline; Premedication; Rats; Rats, Sprague-Dawley; Reperfusion; Time Factors; Vasodilator Agents | 1999 |
Effects of acute and repeated dose administration of caffeine and pentoxifylline on diazepam-induced mouse behavior in the hole-board test.
Topics: Analysis of Variance; Animals; Anxiety; Behavior, Animal; Caffeine; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mice; Pentoxifylline | 1999 |
Chronic effects of xanthines on levels of central receptors in mice.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Brain Chemistry; Caffeine; Calcium Channels; Central Nervous System Stimulants; Cerebral Cortex; Corpus Striatum; Drug Interactions; Gene Expression Regulation; Male; Mice; Nerve Tissue Proteins; Pentoxifylline; Radioligand Assay; Receptors, Cholinergic; Receptors, Drug; Receptors, GABA; Receptors, Purinergic P1; Receptors, Serotonin; Theobromine; Theophylline; Xanthines | 1999 |
Influence of pentoxifylline, A-802710, propentofylline and A-802715 (Hoechst) on the expression of cell cycle blocks and S-phase content after irradiation damage.
Topics: Caffeine; Cell Cycle; Dose-Response Relationship, Drug; Enzyme Inhibitors; G2 Phase; Gentian Violet; Growth Inhibitors; Humans; Indicators and Reagents; Mitosis; Molecular Structure; Nocodazole; Pentoxifylline; Radiation-Sensitizing Agents; S Phase; Time Factors; Tumor Cells, Cultured; Xanthines | 2000 |
The effects of methylxanthines on the mobility of stored turkey sperm.
Topics: Animals; Caffeine; Fertility; Male; Pentoxifylline; Semen Preservation; Sperm Motility; Time Factors; Turkeys; Xanthines | 2000 |
Inhibition of human CYP1A2 activity in vitro by methylxanthines: potent competitive inhibition by 8-phenyltheophylline.
Topics: Acetaminophen; Aryl Hydrocarbon Hydroxylases; Binding, Competitive; Caffeine; Chlorzoxazone; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Gas Chromatography-Mass Spectrometry; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Inhibitory Concentration 50; Kinetics; Magnesium Chloride; Microsomes, Liver; Mixed Function Oxygenases; Models, Chemical; Pentoxifylline; Phenacetin; Protein Binding; Serum Albumin; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Theophylline; Time Factors; Tromethamine; Xanthines | 2001 |
Alleviation of mutagenic effects of polycyclic aromatic agents (quinacrine mustard, ICR-191 and ICR-170) by caffeine and pentoxifylline.
Topics: Aminacrine; Aminoacridines; Antimutagenic Agents; Caffeine; Models, Molecular; Mutagenicity Tests; Mutagens; Nitrogen Mustard Compounds; Pentoxifylline; Polycyclic Aromatic Hydrocarbons; Quinacrine Mustard; Vibrio | 2003 |
Methylxanthines (caffeine, pentoxifylline and theophylline) decrease the mutagenic effect of daunomycin, doxorubicin and mitoxantrone.
Topics: Antimutagenic Agents; Caffeine; Cell Survival; Daunorubicin; Doxorubicin; Mitoxantrone; Mutagenicity Tests; Pentoxifylline; Structure-Activity Relationship; Theophylline; Vibrio; Xanthenes | 2005 |
Mutagenic activity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aminoacridines; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Caffeine; Central Nervous System Stimulants; Doxorubicin; Free Radical Scavengers; Mutagenicity Tests; Neurotoxins; Nitrogen Mustard Compounds; Pentoxifylline; Phosphodiesterase Inhibitors; Theophylline; Vibrio | 2006 |
Regulation of intestinal hPepT1 (SLC15A1) activity by phosphodiesterase inhibitors is via inhibition of NHE3 (SLC9A3).
Topics: 1-Methyl-3-isobutylxanthine; Amino Acid Transport Systems; Caco-2 Cells; Caffeine; Dipeptides; Humans; Hydrogen-Ion Concentration; Pentoxifylline; Peptide Transporter 1; Phosphodiesterase Inhibitors; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Symporters; Theophylline | 2007 |
Hemorheological efficiency of drugs, targeting on intracellular phosphodiesterase activity: in vitro study.
Topics: 1-Methyl-3-isobutylxanthine; Adult; Blood Viscosity; Caffeine; Calcimycin; Calcium; Egtazic Acid; Erythrocyte Aggregation; Hemorheology; Humans; Male; Nifedipine; Papaverine; Pentoxifylline; Phosphodiesterase Inhibitors; Verapamil; Vinca Alkaloids | 2007 |
In vitro antioxidant properties of pentoxifylline and vinpocetine in a rheological model.
Topics: Adult; Blood Viscosity; Caffeine; Calcimycin; Calcium; Egtazic Acid; Erythrocyte Aggregation; Free Radical Scavengers; Hemorheology; Humans; Male; Nifedipine; Papaverine; Pentoxifylline; Phosphodiesterase Inhibitors; Verapamil; Vinca Alkaloids | 2008 |
Caffeine confers radiosensitization of PTEN-deficient malignant glioma cells by enhancing ionizing radiation-induced G1 arrest and negatively regulating Akt phosphorylation.
Topics: Animals; Brain Neoplasms; Caffeine; Cell Line, Tumor; Cell Survival; DNA Damage; G1 Phase; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Genes, p53; Glioma; Humans; Mice; Mutation; Pentoxifylline; Phosphorylation; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Radiation, Ionizing | 2010 |
Effect of post-thaw dilution with caffeine, pentoxifylline, 2'-deoxyadenosine and prostatic fluid on motility of frozen-thawed dog semen.
Topics: Animals; Body Fluids; Caffeine; Cell Survival; Cryopreservation; Deoxyadenosines; Dogs; Hot Temperature; Male; Pentoxifylline; Prostate; Semen Preservation; Solutions; Sperm Motility; Spermatozoa | 2010 |
Caffeine, pentoxifylline and theophylline form stacking complexes with IQ-type heterocyclic aromatic amines.
Topics: Amines; Caffeine; Calorimetry; Carcinogens; Heterocyclic Compounds; Mutagenicity Tests; Pentoxifylline; Salmonella typhimurium; Spectrum Analysis; Theophylline; Vibrio; Xanthines | 2011 |
Xanthine derivatives as activators of alpha-amylase: hypothesis on a link with the hyperglycemia induced by caffeine.
Topics: Animals; Blood Glucose; Caffeine; Enzyme Activation; Enzyme Inhibitors; Hyperglycemia; Pancreas; Pancreatic alpha-Amylases; Pentoxifylline; Starch; Swine; Theobromine | 2013 |
Effect of various concentrations of caffeine, pentoxifylline, and kallikrein on hyperactivation of frozen bovine semen.
Topics: Animals; Caffeine; Cattle; Cryopreservation; Fertilization; Humans; Kallikreins; Male; Pentoxifylline; Semen Preservation; Sperm Motility; Spermatozoa | 2015 |
Sperm motility activation in the critically endangered booroolong frog: the effect of medium osmolality and phosphodiesterase inhibitors.
Topics: Animals; Anura; Caffeine; Fertilization in Vitro; Male; Osmolar Concentration; Pentoxifylline; Phosphodiesterase Inhibitors; Semen Analysis; Sperm Motility; Spermatozoa; Theophylline | 2017 |
Simultaneous determination of pentoxifylline, metabolites M1 (lisofylline), M4 and M5, and caffeine in plasma and dried blood spots for pharmacokinetic studies in preterm infants and neonates.
Topics: Caffeine; Chromatography, High Pressure Liquid; Dried Blood Spot Testing; Humans; Infant, Newborn; Infant, Premature; Pentoxifylline; Plasma; Tandem Mass Spectrometry | 2017 |
Post-thaw Addition of Caffeine and/or Pentoxifylline Affect Differently Motility of Horse and Donkey-Cryopreserved Spermatozoa.
Topics: Animals; Caffeine; Equidae; Female; Horses; Humans; Male; Pentoxifylline; Pregnancy; Sperm Motility; Spermatozoa | 2019 |
Effect of Caffeine and Pentoxifylline Added Before or After Cooling on Sperm Characteristics of Stallion Sperm.
Topics: Animals; Caffeine; Fertility; Horses; Male; Pentoxifylline; Sperm Motility; Spermatozoa | 2020 |
Unique Role of Caffeine Compared to Other Methylxanthines (Theobromine, Theophylline, Pentoxifylline, Propentofylline) in Regulation of AD Relevant Genes in Neuroblastoma SH-SY5Y Wild Type Cells.
Topics: Alzheimer Disease; Caffeine; Cell Line, Tumor; Gene Expression Regulation; Genes, Essential; Humans; Neuroblastoma; Pentoxifylline; Principal Component Analysis; Theobromine; Theophylline; Transcription, Genetic; Xanthines | 2020 |
Modulatory Effects of Caffeine and Pentoxifylline on Aromatic Antibiotics: A Role for Hetero-Complex Formation.
Topics: Anti-Bacterial Agents; Bacteria; Caffeine; Central Nervous System Stimulants; Drug Interactions; Heterocyclic Compounds; Microbial Sensitivity Tests; Pentoxifylline; Phosphodiesterase Inhibitors | 2021 |
Methylxanthines Induce a Change in the AD/Neurodegeneration-Linked Lipid Profile in Neuroblastoma Cells.
Topics: Alzheimer Disease; Caffeine; Cell Line, Tumor; Cholesterol; Humans; Lipids; Neural Stem Cells; Neuroblastoma; Neurodegenerative Diseases; Pentoxifylline; Theobromine; Theophylline; Triglycerides; Xanthines | 2022 |